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Introduction
Approximately 40% of children with a severe form of sickle cell disease (SCD) will be affected by silent cerebral infarction (SCIs) by the age of 14 1 . SCIs are defined as an area of abnormal hyperintensity on magnetic resonance imaging (MRI) of the brain in a patient without a history or physical findings of a focal neurological deficit 2 . Most SCIs are located in the white matter (WM) and visible as white matter hyperintensities (WMHs) on MRI. SCIs are associated with diminished neurocognitive functioning, potentially hampering social and academic achievement 3, 4 . Affected patients are at risk for progression of SCIs and overt stroke 5 . Studies on risk factors for SCIs are scarce and therapeutic options are still under investigation 6 .
Two possible disease mechanisms for the development of WMHs have been proposed. First, vasoocclusion could occur in the blood vessels of the brain, leading to infarcts in the white matter. Vasoocclusion occurs in the setting of endothelial and coagulation activation, increased expression of adhesion molecules and impaired vasodilatation due to a decreased bioavailability of nitric oxide [7] [8] [9] .
These are well recognized phenomena even in young patients, leading to systemic vascular endothelial dysfunction. Intracerebral involvement is supported by the finding of diffuse thickening and sclerosis of intracerebral arterioles as described in one of the few autopsy studies in sickle cell disease 10 . Although in other disease conditions white matter or lacunar infarcts in the brain are associated with local small vessel pathology and are called 'cerebral small vessel disease', definite evidence for a vascular etiology of SCIs in sickle cell disease is lacking 11 . Some evidence for the role of endothelial dysfunction in the etiology of WMHs was demonstrated in a small study which found lower concentrations of tissue plasminogen activator (t-PA) and ADAMTS13 in 9 SCD patients with SCIs compared to 38 patients without SCIs 12 . The main risk factor for SCIs seems to be a low level of hemoglobin (Hb), as demonstrated in a multivariate analysis in a large (n=132), prospective study by Bernaudin et al., as well as in the baseline results of the SITT (Silent Infarct Transfusion Trial) (n=814), and in a retrospective study (n=65) in very young children (mean age 3.7±1.1 years) 1, 13, 14 . These identified risk factors suggest that hematological factors such as the level of hemoglobin and perhaps endothelial and/or coagulation activation play a role in the etiology of SCIs.
A second, additional hypothesis for the development of SCIs is related to altered cerebral blood flow (CBF). Previous studies using an arterial spin labeling (ASL) technique on MRI have demonstrated an increased CBF in the gray matter (GM) of children with SCD compared to controls, probably as compensatory mechanism for the chronic anemia 15, 16 . Cerebral reactivity, i.e. vasodilatory capacity in reaction to triggers such as hypercapnia, has been demonstrated to be significantly reduced in patients with SCD compared to controls 17 . This may lead to compromised CBF during episodes of increased metabolic demand such as fever or an acute drop in hemoglobin which could subsequently lead to cerebral ischemia. Indeed, acute SCIs have been identified by diffusion weighted imaging in children experiencing an acute decrease in hemoglobin 18 . The association between baseline CBF, i.e. during steady disease state, and the risk of SCIs is unclear. Patients with a high baseline CBF could be at risk for the development of SCIs due to insufficient reserve capacity of CBF. On the other hand, SCIs could potentially lead to a decrease in CBF in the white matter because blood flow to necrotic tissue is decreased and subsequently CBF would become lower in the white matter. Therefore, it is of particular interest to study CBF in GM and WM separately.
Probably both mechanisms -endothelial dysfunction leading to small vessel disease and insufficient CBF -are important factors in the etiology of SCIs in sickle cell disease. Additionally, besides being influenced directly by hemoglobin 17, 19 and hematocrit 20, 21 CBF could also be affected by endothelial and coagulation activation due to altered hemorheology and viscosity. The interaction between SCIs, endothelial dysfunction and CBF is described in the proposed hypothetical model in Figure 1 . To help elucidate these interactions, our aim was to study the association between the presence and size of WMHs and parameters of endothelial and coagulation activation and CBF in GM and WM. 22 ), chronic blood transfusion therapy, bone marrow transplantation, contra-indications for MRI and concomitant major health problem. Because the present study was part of a larger study that included a neuropsychological evaluation, we excluded patients with an inability to undergo neurocognitive testing (e.g. insufficient knowledge of the Dutch language). Patients had to be in a steady disease state, i.e. the absence of infection or crisis for >4 weeks prior to study visit.
All patients underwent a neurological examination performed by a trained pediatric neurologist (ME) who was blinded for imaging results. Results were scored according to the Pediatric Stroke Outcome Measure (PSOM). The PSOM yields a score ranging from 0 (no deficits) to 10 (severe deficits on all 5 subscales) (Supplemental Table 1 ) 23 . Focal neurological deficits were described separately. Genotype was 
Laboratory parameters
Blood sampling was performed on the day of study visit. Basic hematologic and biochemical parameters
were assessed using standard in-house procedures. Percentage of fetal hemoglobin (HbF) was measured using high-performance liquid chromatography (HPLC). Free hemoglobin (free Hb) was measured using spectrophotometry on a Shimadzu UV-2401 PC. Von Willebrand factor (VWF) plasma concentration was measured by enzyme-linked immunosorbent assay (ELISA) (Dakopatts) 24 . VWF activity was determined on an automated coagulation analyzer (Behring Coagulation System, BCS) with reagents and protocol from the manufacturer (Siemens Healthcare Diagnostics, Marburg, Germany). VWF propeptide was assessed by ELISA using CLB-pro, an antibody against VWF propeptide 25 . The activated conformation of VWF was measured by semi-automated ELISA on a TECAN Freedom EVO robot (Tecan, Männedorf, Switzerland) using an antibody against active VWF as described previously 26 .
Prothrombin fragment 1 and 2 (F1+2) was measured by ELISA using a mouse anti-human antibody 27 .
Thrombin-antithrombin complex (TAT) was measured by ELISA using a rabbit anti-human antibody (Enzygnost) 28 . ADAMTS-13 was determined as described previously using a semi-automated essay 29 .
Glucose-6-phosphate dehydrogenase activity (G6PD) was measured in all boys using spectrophotometry.
Magnetic Resonance Imaging Acquisition
Patients were imaged on a 3.0 Tesla (3T)Intera with a SENSE-8-channel head coil (n=32)or on a 3.0 T Ingenia with a SENSE-15-channel head coil (n=8), both Philips Healthcare, Best, the Netherlands. The Mapping, Wellcome Trust Centre for Neuroimaging, London, UK) were used for offline data processing with custom-built software. After 3D rigid-body motion correction, the control-label pairs were pairwise subtracted and a robust perfusion-weighted map was created using linear robust regression with
Huber's M-estimator 31 . These perfusion-weighted maps were converted into CBF maps using a single compartment quantification model, assuming that the label decays with the T1 of blood 32, 33 . A single M0
value -obtained in a previous study -was used for all participants 34 .
ASL post-processing: spatial normalization
The 2D T2-weighted anatomical scan was segmented into GM and WM tissue probability maps. All CBF maps were transformed into anatomical space by a rigid-body registration of the averaged control image on the GM tissue probability maps. A two-stage approach was used to spatially normalize anatomical differences and residual EPI geometric distortion differences between subjects. First, the T1 tissue probability maps were spatially normalized using the Diffeomorphic Anatomical Registration analysis using Exponentiated Lie algebra (DARTEL) algorithm, with the resulting normalization fields applied to the average control images 35 . Secondly, the average control images were segmented into probability maps that were also normalized using DARTEL. Finally, EPI geometric distortion was corrected by warping the average control images to the average T2. All estimated transformations were applied to the corresponding CBF maps. CBF was calculated for GM and WM separately, for the whole brain and per hemisphere. In addition, we calculated CBF for the total normal appearing WM by excluding the WMHs itself.
White matter hyperintensities
All scans were evaluated by two independent observers (CBLMM and VvdL or HJMMM); discrepancies were resolved by mutual consent. The observers were blinded for all clinical information and study results except for the diagnosis of SCD. We defined WMHs using the Standards for Reporting Vascular changes on Neuroimaging (STRIVE) definition: a white matter hyperintensity of presumed vascular origin being a hyperintensity of variable size in the white matter on the FLAIR scan, without cavitation.
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Incidental findings were described separately.
WMH volume was obtained semi-automatically by the procedure as illustrated in Figure 2 . On all FLAIR slices WMHs were visually identified and manually selected as regions of interest (ROIs) (Figure 2a ) with a wide margin using ITK-Snap 37 . These ROIs were used for an intensity-based segmentation. GM was segmented on all FLAIR scans (Figure 2b) , and the mean GM intensity of each patient was calculated.
All voxels with a signal intensity >1.02 times of the average GM intensity were selected (Figure 2c ). All selected voxels within the manually delineated ROIs were labeled as WMH (Figure 2d ). Stenosis of intracerebral arteries were rated on the TOF MRA by an experienced neuro-radiologist (CBLMM) as follows: <25%; 25-50%; 50-75%; 75-99% or occlusion. 
Statistical analysis
For comparison of continuous variables between groups, we used a Student's t-test or a Mann-Whitney U test when data was not normally distributed. For categorical variables, we performed a Fisher's exact test. In patients with WMHs, we investigated the association between potential laboratory risk factors and CBF on one side, and WMH volume on the other side using linear regression analysis. Because the distribution of WMH volume was skewed we used a rank score of WMH volume as the outcome in the linear regression analyses. In addition, we investigated the association between potential laboratory risk factors and CBF using linear regression.
Results
Patient population
We included 40 patients (for inclusion and exclusion, see Supplemental Figure 1 ).Mean age was 12.1 ± 2.6 years, 58% was male and most patients had homozygous SCD (95%); the remaining patients HbSß previous overt stroke and/or chronic blood transfusion therapy (n=10); mental retardation or severe depression (n=3); other major health problem (n=2). Reasons for drop out: non-compliant with appointments (n=3); unable to make appointment due to frequent crisis (n=2); child refused MRI (n=1).
Description of neurological damage
WMHs were present in half of the patients (Table 1) neurological examination was normal. Gray matter involvement was seen in 2 other patients. In one boy we discovered a small (<15 mm) cortical infarct in the occipital lobe with a normal neurological evaluation; this patient had a WMH volume of 697 mm 3 , stenosis of intracranial arteries could not be evaluated because of motion artifacts on the TOF scan but TCD was normal. One girl had two small (<5mm) cortical infarcts in the frontal and temporal lobe, she did not have any WMHs and neurological examination was normal. 
Cerebral blood flow and its association with WMHs
Total GM and WM CBF did not differ between patients with WMHs or patients without WMHs. In patients with WMHs, there was no association between WMH volume and CBF in any brain region using linear regression analysis (p>0.10 for all associations). CBF did not differ between boys and girls.
In patients with WMHs, we calculated CBF in normal appearing WM by excluding the WMHs itself.
CBF in normal appearing WM was 35.9 mL/100g/min, compared to mean CBF in WM of 37.3 mL/100g/min in patients without WMHs (p=0.41).
Association between CBF and laboratory parameters including endothelial and coagulation activation
Higher CBF values in GM and WM were both significantly associated with lower Hb (regression . HbF is one of the most important known modifiers of disease severity in SCD, predicting mortality, pain rates, dactylitis and acute chest syndrome [38] [39] [40] [41] [42] . Because HbF does not polymerize and reduces the concentration of HbS, high levels can inhibit polymerization and the subsequent detrimental effects such as hemolysis and vasoocclusion. 43 Increasing HbF by using hydroxyurea has been shown to decrease several complications and decrease hemolysis, but it is unclear whether it can protect against the development of WMHs 44, 45 .
We observed a trend towards a lower VWF propeptide in patients with a larger WMH volume. This is in accordance with the results of Colombatti et al. who found some evidence for a higher level of endothelial dysfunction in patients with SCIs. 12 Interestingly, recent insights suggest that endothelial dysfunction plays a pivotal role in the occurrence of SCIs in other patient groups such as vascular dementia 46, 47 .
In addition, we investigated the association between WMHs and CBF and did not find any differences in CBF in GM or WM between patients with and without WMHs. CBF in normal appearing WM also did not differ from CBF in the white matter of patients without any WMHs. This may be due to the fact that we performed a cross-sectional study and only investigated patients during steady disease state. Perhaps CBF could become insufficient in our patients during episodes of increased demand. Future studies should therefore focus on the dynamics of CBF in order to elucidate its role in the etiology of WMHs. 
Strengths and Limitations
MRI scanning was performed using a 3T scanner which yields high resolution images, and additionally we used a semi-automatic method to delineate WMHs, leading to a good estimation of the total volume of the WMHs. Instead of only calculating CBF in the GM, we used a state of the art ASL method and were able to quantify CBF in the WM and GM separately. We used a broad panel of markers of endothelial and coagulation activation to investigate the association with WMHs and CBF.
We specifically studied risk factors for WMHs in SCD, regardless of neurological status. We realize this
is not in line with most previous studies on SCIs, that mostly defined SCIs as areas of abnormal hyperintensity on MRI of the brain in a patient with no history or physical findings of a focal neurological deficit. Extensive WMHs or a WMH located at a vital location could result in focal neurological deficits and would lead to the exclusion of these patients when using this latter definition of SCIs, while the etiology of the lesions is similar. Because our objective was to study risk factors for WMHs, we did not exclude these patients. As this was an explorative study, we did not perform a correction for multiple testing; this should be taken into account when interpreting the results.
Conclusion
Our study showed that boys have a higher risk of WMHs and that a high HbF concentration seems protective for the development of WMHs. Lower ADAMTS13 levels were associated with lower CBF in the WM, suggesting that endothelial activation could potentially hamper CBF. Our findings suggest that fetal hemoglobin and endothelial dysfunction may be involved in the pathogenesis of WMHs in patients with SCD, possibly mediated through altered CBF.
